3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
18
Carcinoma, Hepatocellular
9
Neoplasms
8
Melanoma
7
Squamous Cell Carcinoma of Head and Neck
6
Nasopharyngeal Carcinoma
6
Triple Negative Breast Neoplasms
5
Esophageal Neoplasms
5
Neoplasm Metastasis
4
Esophageal Squamous Cell Carcinoma
4
Colonic Neoplasms
4
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Solid Cancers
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Gastric / Gastroesophageal Junction Adenocarcinoma
2
EBV-associated Tumors
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Bites and Stings
2
Biliary Tract Neoplasms
2
Advanced Solid Tumors
2
Interventions
Fluorouracil
16
Oxaliplatin
14
Nivolumab
14
Leucovorin
13
pembrolizumab
9
Paclitaxel
9
Capecitabine
9
Radiotherapy
6
Radiation
6
durvalumab
5
Taxes
5
Irinotecan
5
Cisplatin
5
Trastuzumab
4
Specimen Handling
4
Drug Therapy
4
Carboplatin
4
tremelimumab
3
dehydroftorafur
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Folfox protocol
3
Endoscopy
3
Docetaxel
3
Biopsy
3
zimberelimab
2
zanidatamab
2
trastuzumab deruxtecan
2
tislelizumab
2
futibatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Immune Checkpoint Inhibitors
×
1 year
×
Clear all
No trials found.